Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol in Diarrhea-Predominant Irritable Bowel Syndrome
NCT01253408Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Mayo Clinic. Started Sep 2009; status: completed.
02
Drugs
dronabinol
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01253408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01253408.